中文名 | VU0238441 |
英文名 | VU0238441 |
别名 | 化合物VU0238441 7-氯-1-(4-(三氟甲基)苄基)二氢吲哚-2,3-二酮 |
英文别名 | VU0238441 7-Chloro-1-(4-(trifluoromethyl)benzyl)indoline-2,3-dione 7-chloro-1-[[4-(trifluoromethyl)phenyl]methyl]indole-2,3-dione 7-Chloro-1-[[4-(trifluoromethyl)phenyl]methyl]-1H-indole-2,3-dione 1H-Indole-2,3-dione, 7-chloro-1-[[4-(trifluoroMethyl)phenyl]Methyl]- |
CAS | 85511-68-8 |
化学式 | C16H9ClF3NO2 |
分子量 | 339.7 |
密度 | 1.500±0.06 g/cm3(Predicted) |
沸点 | 441.7±55.0 °C(Predicted) |
溶解度 | 溶于DMSO |
酸度系数 | -3?+-.0.20(Predicted) |
存储条件 | Sealed in dry,Room Temperature |
靶点 | M5 mAChR, M5 : 2.1μM(EC50), |
体外研究 | VU0238441 is an analogue of VU0119498. |
参考资料 展开查看 | [1]. Thomas M Bridges, et al. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM. Bioorg Med Chem Lett. 2010 Jan 15;20(2):558-62.[2]. Thomas M Bridges, et al. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. J Med Chem. 2009 Jun 11;52(11):3445-8. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.944 ml | 14.719 ml | 29.438 ml |
5 mM | 0.589 ml | 2.944 ml | 5.888 ml |
10 mM | 0.294 ml | 1.472 ml | 2.944 ml |
5 mM | 0.059 ml | 0.294 ml | 0.589 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!